The Future Is Bright for IVIG Market (Intravenous Immunoglobulin Market) - Forecast Upto 2022
Intravenous immunoglobulin (IVIG) is used in the treatment of deficiency disorders such as hypogammaglobulinemia, Kawasaki disease, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Globally, the rise in immunoglobulin deficiency and the associated disorders drive the use of IVIG in clinical settings. GAMUNEX-C, Flebogamma DIF 5% & 10%, Gammaplex, and Kiovig are the key regulated products approved for use in therapy settings. There are several products that are available in market as "off-label" products, including Gammagard Liquid intravenous, Gammagard S/D...
View full press release